-

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against 17 Education & Technology Group Inc. (YQ)

SAN DIEGO--(BUSINESS WIRE)--The Class: Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons or entities that purchased or otherwise acquired 17 Education & Technology Group Inc. (NASDAQ: YQ) securities in connection with the Company's December 2020 initial public offering ("IPO"), for violations of the Securities Act of 1933. 17EdTech purports to be a leading education technology company that provides K-12 education services in the People's Republic of China ("PRC").

If you would like more information about 17 Education & Technology Group Inc. misconduct, click here.

What is this Case About: 17 Education & Technology Group Inc.(YQ) Misled Investors Regarding the Viability of its Long-Term Business Prospects

According to the complaint, defendants held the Company's IPO on December 4, 2020, issuing approximately 27,400,000 American Depository Shares ("ADSs") at $10.50 per ADS. Just a year later, 17EdTech ceased its core offering of tutoring services for students K-12. PRC authorities have been targeting private education and tutoring companies since at least February 2019, when Chinese authorities publicly proposed a 2018-2022 plan for modernizing Chinese education, which included restricting foreign investment in education and reducing the burden of education and training. On July 23, 2021, Chinese authorities formally revealed to the public continued regulations banning after-school tutoring companies that teach the school curriculum from making profits, raising capital, or going public.

The offering documents supporting 17EdTech's IPO failed to disclose the Company's K-12 tutoring services would be shut down in a year's time, effectively curtailing and/or ending 17EdTech's core business. As the Company disclosed the impact of the ban on after-school tutoring companies, 17EdTech's stock spiraled downwards. Since the IPO, as it disclosed material adverse facts that it had omitted from the offering documents, 17EdTech's stock has declined approximately 85%.

Next Steps: If you acquired shares of 17EdTech pursuant to the Company's IPO, you have until September 19, 2022, to ask the court to appoint you lead plaintiff for the class. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against 17 Education & Technology Group Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:YQ

Release Summary
17 Education & Technology Group Inc.(YQ) Misled Investors Regarding the Viability of its Long-Term Business Prospects
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Vistagen Therapeutics, Inc. Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Vistagen Therapeutics, Inc. (NASDAQ: VTGN) common stock between April 1, 2024 and December 16, 2025. Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. For more information, submit a form, email attorney Aaron Dumas...

Investor Notice: Robbins LLP Informs Investors of the Securities Class Action Against Oracle Corporation

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a class action was filed on behalf of all persons and/or entities who purchased or otherwise acquired Oracle Corporation (NYSE: ORCL) Senior Notes issued pursuant to the Shelf Registration Statement filed with the SEC on March 15, 2024, and as supplemented on September 25, 2025. Oracle is an Austin, Texas-based company that sells database software, enterprise applications, and cloud infrastructure and hardware. For more information,...

Investor Notice: Robbins LLP Informs Investors of the Smart Digital Group Limited Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Smart Digital Group Limited (NASDAQ: SDM) securities between May 5, 2025 and September 26, 2025. Smart Digital, together with its subsidiaries, provides internet media, business planning and consulting, event planning and execution, and software customization and marketing services in Mainland China and Macau. For more information, submit a fo...
Back to Newsroom